TMT, biotech fund Oceanpine raises $400 million

After launching in 2016 with GP internal capital, Oceanpine announced a final closing of its Oceanpine Capital Fund II totaling $400 million.

The Beijing-based firm invests . . .

Continue Reading With a Free Trial

Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.

Already a subscriber? Log in.

Related Articles

Back to top button

Get our daily news digest
in your inbox

Our FREE mailing list brings you daily alts intel.

Thank you for subscribing.

Something went wrong.